Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net loss	$ (4,314,000)	$ (14,102,000)
Less: loss from discontinued operations, net of taxes of $0	(436,000)	(622,000)
Loss from continuing operations, net of taxes	(3,878,000)	(13,480,000)
Adjustments to reconcile loss from continuing operations to cash used in operating activities:
Depreciation and amortization	3,394,000	2,986,000
Amortization of debt issuance costs	27,000	164,000
Deferred tax expense (benefit)	105,000	(3,095,000)
Provision for (recovery of) bad debt reserves	85,000	(336,000)
(Gain) loss on disposal of property and equipment	(1,000)	16,000
Impairment loss on tangible assets	672,000	1,816,000
Impairment loss on intangible assets		8,288,000
Issuance of common stock for services	161,000	178,000
Stock-based compensation	96,000	69,000
Changes in operating assets and liabilities of continuing operations
Restricted cash		35,000
Accounts receivable	41,000	(140,000)
Unbilled receivables	(1,554,000)	1,808,000
Prepaid expenses, inventories and other assets	293,000	2,225,000
Accounts payable, accrued expenses and unearned revenue	914,000	(1,869,000)
Cash provided by (used in) continuing operations	355,000	(1,335,000)
Cash used in discontinued operations	(464,000)	(710,000)
Cash used in operating activities	(109,000)	(2,045,000)
Cash flows from investing activities:
Purchases of property and equipment	(200,000)	(104,000)
Proceeds from sale of property and equipment	7,000	30,000
Proceeds from/(payment to) finite risk sinking fund	5,845,000	(76,000)
Cash provided by (used in) investing activities of continuing operations	5,652,000	(150,000)
Cash provided by investing activities of discontinued operations	52,000	68,000
Cash provided by (used in) investing activities	5,704,000	(82,000)
Cash flows from financing activities:
Repayments of revolving credit borrowings	(34,979,000)	(41,223,000)
Borrowing on revolving credit	31,176,000	44,137,000
Proceeds from issuance of common stock upon exercise of warrants/options		156,000
Release of proceeds for stock subscription for Perma-Fix Medical S.A. previously held in escrow		64,000
Payment of debt issuance costs		(97,000)
Principal repayments of long term debt	(914,000)	(1,199,000)
Principal repayments of long term debt-related party		(1,000,000)
Cash (used in) provided by financing activities of continuing operations	(4,717,000)	838,000
Effect of exchange rate changes on cash	14,000	(1,000)
Increase (decrease) in cash	892,000	(1,290,000)
Cash at beginning of period	163,000	1,435,000
Cash at end of period	1,055,000	145,000
Supplemental disclosure:
Interest paid	252,000	309,000
Income taxes paid	$ 17,000	$ 41,000